![Douglas S. Krafte](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Douglas S. Krafte
Technik-/Wissenschafts-/F&E-Leiter bei
Neusentis, Inc.
Profil
Douglas S.
Krafte is currently the Director at Icagen-T, Inc. He is also the Chief Scientific Officer at Neusentis, Inc. since 2011.
Additionally, he is a Member of the Society For Neuroscience, The Biophysical Society, and The Society of General Physiologists.
Previously, he worked as a Group Leader-Ion Channel Research at Aurora Biosciences Corp.
from 1997 to 1999.
He also served as the Chief Scientific Officer at Icagen, Inc. Dr. Krafte holds a doctorate degree from the University of Rochester and an undergraduate degree from Vanderbilt University.
Aktive Positionen von Douglas S. Krafte
| Unternehmen | Position | Beginn |
|---|---|---|
Neusentis, Inc.
 Neusentis, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel orally administered small molecule drugs | Technik-/Wissenschafts-/F&E-Leiter | 17.12.2009 |
The Biophysical Society
 The Biophysical Society Miscellaneous Commercial ServicesCommercial Services Operates as biological society | Corporate Officer/Principal | - |
Society For Neuroscience
 Society For Neuroscience Miscellaneous Commercial ServicesCommercial Services Operates brain and nervous system professional society for scientists & physicians | Corporate Officer/Principal | - |
The Society of General Physiologists
 The Society of General Physiologists The Society of General Physiologists is a company based in Woods Hole, MA. | Corporate Officer/Principal | - |
Icagen-T, Inc.
 Icagen-T, Inc. BiotechnologyHealth Technology Engages in development of pharmaceutical drugs for therapeutic needs | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Douglas S. Krafte
| Unternehmen | Position | Ende |
|---|---|---|
Icagen, Inc.
 Icagen, Inc. Medical SpecialtiesHealth Technology Develops pharmaceutical and drug discovery instruments | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2020 |
Aurora Biosciences Corp.
 Aurora Biosciences Corp. BiotechnologyHealth Technology Designs and develops proprietary drug discovery systems, services and technologies | Corporate Officer/Principal | 01.01.1999 |
Ausbildung von Douglas S. Krafte
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
50
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Rochester Christian University
 Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aurora Biosciences Corp.
Aurora Biosciences Corp. BiotechnologyHealth Technology Designs and develops proprietary drug discovery systems, services and technologies | Health Technology |
Neusentis, Inc.
Neusentis, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel orally administered small molecule drugs | Health Technology |
Icagen, Inc.
Icagen, Inc. Medical SpecialtiesHealth Technology Develops pharmaceutical and drug discovery instruments | Health Technology |
Vanderbilt University
 Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Society For Neuroscience
Society For Neuroscience Miscellaneous Commercial ServicesCommercial Services Operates brain and nervous system professional society for scientists & physicians | Commercial Services |
The Biophysical Society
The Biophysical Society Miscellaneous Commercial ServicesCommercial Services Operates as biological society | Commercial Services |
The Society of General Physiologists
The Society of General Physiologists The Society of General Physiologists is a company based in Woods Hole, MA. | |
Icagen-T, Inc.
Icagen-T, Inc. BiotechnologyHealth Technology Engages in development of pharmaceutical drugs for therapeutic needs | Health Technology |
Wählen Sie MarketScreener 
